A medication intake state confirmation module and system

Abstract

The utility model discloses a medicine taking state confirmation module and system, include: trigger module, response user completes the confirmation action of taking medicine, generates a trigger signal, feedback module provides a state feedback signal of a continuous predetermined length under the control of trigger signal, in the duration, state feedback signal provides the visual feedback of continuous or the voice feedback of the interaction that can provide, indicate that the medicine taking behavior has occurred recently. The medicine taking state confirmation system of the utility model has integrated above -mentioned module, can be medicine integrated formula system, intelligent medicine box integrated formula system, mobile terminal integrated formula system, wearable equipment integrated formula system or collaborative system. The utility model passes through " trigger - feedback " closed loop logic, and the medicine taking action of disposable is converted into a state feedback signal of a continuous predetermined length, effectively prevents the occurrence of repeated medicine taking and the missing of taking medicine, and solves the confirmation and the traceability problem of medicine taking behavior.

Description

Technical Field

[0001] This utility model relates to the field of intelligent medical and health monitoring technology, and in particular to a medication status confirmation module and system. Background Technology

[0002] In the field of intelligent healthcare and health monitoring, especially in the daily management of patients with chronic diseases, timely and accurate medication administration is a crucial factor affecting treatment outcomes. To assist users (especially the elderly, those with forgetfulness, or those taking multiple medications) in managing their medication, existing technologies primarily employ the following two types of solutions:

[0003] Both passive reminder solutions based on mobile terminals and smart pillbox solutions have the following drawbacks:

[0004] 1. Passive reminders, unable to confirm actions: Common mobile terminal apps or alarm clocks only issue reminders or notifications at specific times, and cannot confirm whether the user has actually taken the medication. Users may still forget or take the medication repeatedly.

[0005] 2. Smart pillboxes are complicated to operate: Smart pillboxes are linked to a mobile app to confirm medication time, which is complicated to operate and not user-friendly for the elderly.

[0006] 3. Lack of continuous status feedback: The above-mentioned solutions, after the moment of reminder or recording, fail to provide a continuous, intuitive visual signal indicating that "medication has been taken." When users cannot recall whether they have taken medication in the short term, there is no reliable physical evidence to verify, which can easily lead to anxiety or even duplicate medication. Studies have shown that memory impairment is negatively correlated with blood pressure control levels, and systolic blood pressure is an independent risk factor affecting memory function. In a study of medication adherence in 50 elderly hypertensive patients, as many as 29 cases (58%) had repeated doses of antihypertensive drugs on a single day during the follow-up period ("The Influence of Memory Decline on Blood Pressure Control in Elderly Hypertensive Patients and Countermeasures"; China Primary Health Care; 2013-06-10; Ma Yong, Chen Min, Xue Jingjing, He Ming, Tian Lei).

[0007] Based on their own long-term experience with medication, the inventors discovered that the uncertainty and anxiety users experience regarding whether or not to take medication after taking it are not evenly distributed throughout the entire dosing interval, but are highly concentrated within a finite time period after taking the medication (e.g., 0.5-4 hours after taking the medication). Existing technologies do not provide solutions for this specific psychological need of users.

[0008] Therefore, how to provide a medication status confirmation module and system to effectively prevent duplicate medication and missed medication, fundamentally solve the problem of medication behavior confirmation and traceability, and alleviate users' anxiety about "whether or not to take medication" has become a goal that the industry urgently needs to improve. Utility Model Content

[0009] The technical problem to be solved by this utility model is to provide a medication status confirmation module and system that can directly associate with medication actions, trigger and provide continuous status feedback, thereby effectively preventing duplicate medication and missed medication, fundamentally solving the problem of confirming and tracing medication behavior, and alleviating users' anxiety about "whether or not to take medication".

[0010] To solve the above-mentioned technical problems, the present invention adopts the following technical solution:

[0011] In a first aspect, this utility model provides a medication status confirmation module, including:

[0012] The trigger module is used to generate a trigger signal in response to the user's confirmation action of completing medication administration;

[0013] A feedback module is configured to provide a status feedback signal for a predetermined duration under the control of the trigger signal; wherein, during the duration, the status feedback signal provides continuous visual feedback or interactive voice feedback to indicate that medication has been taken recently.

[0014] As a further improvement of this utility model, the predetermined duration is configured to cover the peak period when the user experiences memory uncertainty and medication anxiety after taking the medication.

[0015] Secondly, this utility model also provides a medication status confirmation system, which integrates the aforementioned medication status confirmation module.

[0016] Furthermore, the medication status confirmation system is a drug-integrated system;

[0017] The integrated drug system includes a drug packaging body, which is provided with at least one drug and a chemiluminescence or chemichromic time indication module paired with each drug; the chemiluminescence or chemichromic time indication module serves as the trigger module and feedback module, and is used to activate chemiluminescence or chemichromic change under the control of a trigger signal and maintain it for a predetermined duration.

[0018] Furthermore, the chemiluminescence or chemical color change time indication module is in the form of a capsule, which contains a first chemical component and a second chemical component that are isolated from each other. After the first chemical component and the second chemical component are mixed after the capsule is broken, the chemiluminescence or chemical color change is activated and maintained for a predetermined time.

[0019] Furthermore, the drug packaging body is a blister pack, each unit of which has at least two independent chambers arranged side by side; the at least two independent chambers include a first chamber for containing the drug and a second chamber for coating a chemically discoloring component; the first chamber and the second chamber share the same aluminum foil sealing layer;

[0020] The chemical color-changing components in the second chamber activate a color change process that lasts for a predetermined duration after the aluminum foil sealing layer is torn open and exposed to air.

[0021] Furthermore, the chemical color-changing component contained in the second chamber includes ferrous sulfate hydrogel; the ferrous sulfate hydrogel in the second chamber oxidizes upon contact with air after the aluminum foil sealing layer is torn open, thereby producing a color change that lasts for a predetermined period of time.

[0022] Furthermore, the feedback module is an electronic feedback module, and the medication status confirmation system is an integrated system of smart pillbox, mobile terminal, and / or wearable device.

[0023] Furthermore, the intelligent pillbox integrated system includes a shell, a pill compartment, a control module, and the triggering module and feedback module;

[0024] The medicine compartment is located inside the shell, and the trigger module and feedback module are located on the smart medicine box. The trigger module is connected to the feedback module through the control module.

[0025] The control module is configured such that once a trigger signal is received, the control feedback module continues to work for a predetermined duration.

[0026] The triggering module uses a confirmation button, voice confirmation, or a sensor built into the smart pillbox. The sensor built into the smart pillbox automatically generates a trigger signal after detecting a medicine-taking action.

[0027] The smart pillbox has built-in sensors, including pressure sensors, switch sensors, photoelectric sensors, or camera sensors.

[0028] The feedback module is an indicator light or a display icon on the screen; the feedback module continuously displays for a predetermined duration in a constant, flashing, or gradual manner; or the feedback module is a voice feedback module; after receiving a query request from the user to confirm the medication status, the voice feedback module provides corresponding voice feedback based on whether the medication has been taken.

[0029] Furthermore, the mobile terminal integrated system includes a mobile terminal body and a mobile terminal screen, and the trigger module and feedback module are provided on the mobile terminal screen;

[0030] The triggering module is a digital triggering module, which generates a trigger signal through user clicks or voice confirmation commands on the mobile terminal screen;

[0031] The feedback module is an indicator light or a display icon on the screen, which continuously displays for a predetermined duration in a constant, flashing, or gradual manner; or the feedback module is a voice feedback module; after receiving a query request from the user to confirm the medication status, the voice feedback module provides corresponding voice feedback based on whether the medication has been taken.

[0032] Furthermore, the wearable device integrated system includes a wearable device body, a control module, and the trigger module and feedback module;

[0033] The triggering module can be a physical button, a touch sensor, a capacitive sensing area, a voice receiving module, or a camera module.

[0034] The feedback module includes a miniature LED array, optical fiber, or a display indicator on the device's own screen; or the feedback module is a voice feedback module; after receiving a user's query request to confirm medication status, the voice feedback module provides corresponding voice feedback based on whether the user has taken medication.

[0035] The control module is configured to: once it receives a trigger signal from the user through the trigger module, set the medication status to "medication taken" and continue for a predetermined duration; when the user wants to obtain information on whether the medication has been taken, provide medication status information through vision or hearing, thereby providing a status indication that is bound to the user's identity, always on their person, and extremely convenient.

[0036] Furthermore, the wearable device integrated system includes a smart ring, smart bracelet, smartwatch, or smart badge.

[0037] Furthermore, the smart pillbox integrated system, the mobile terminal integrated system, and the wearable device integrated system are mutually collaborative systems; through wired or wireless communication connections, the smart pillbox integrated system and the mobile terminal integrated system automatically send trigger signals to the wearable device integrated system worn by the user, triggering the feedback module of the wearable device integrated system to display.

[0038] By adopting the above technical solution, this utility model has at least the following beneficial effects:

[0039] 1. Provides solid evidence of medication use, fundamentally preventing duplicate and missed doses: The feedback module creates a continuous visual signal and / or interactive voice feedback that is closely coupled with the medication action, providing users with an objective and reliable basis for verification, completely eliminating medication errors caused by memory lapses, and greatly improving medication safety.

[0040] 2. Achieve seamless recording and user-friendly interaction: Through simple triggering mechanisms (such as squeezing a capsule, pressing a button, sensor detection, etc.), users do not need to perform any complicated recording operations. It is integrated into the natural medication process, providing a smooth experience, which is especially friendly to elderly users.

[0041] 3. Identity binding and ultimate convenience (unique advantages of wearable device integrated systems): Wearable devices are bound to individual users rather than medicines or smart pillboxes, realizing true "personalized medication management". Since they are always worn, status checks are readily available, eliminating the risk of missed checks due to the device not being nearby.

[0042] 4. High flexibility and universality: The essence of this utility model is the "trigger-feedback" logic, rather than relying on specific hardware. Therefore, it can be adapted to different carriers (such as drug packaging, smart pillboxes, mobile phones, and wearable devices), meet the needs of users at different consumption levels and in different technological environments, and has a wide range of applications.

[0043] 5. The system is reliable and low-cost: Whether it is chemiluminescence, simple electroluminescence display or electronic voice feedback, the implementation scheme is very mature and reliable, and the cost per use is extremely low, which is conducive to large-scale promotion and application.

[0044] 6. Achieve natural, multimodal human-computer interaction: By introducing triggering methods such as voice recognition and image recognition, and voice feedback, the recording and querying of medication status becomes more natural and intuitive, resulting in a better user experience. Attached Figure Description

[0045] The above is merely an overview of the technical solution of this utility model. In order to better understand the technical means of this utility model, the following describes this utility model in further detail with reference to the accompanying drawings and specific embodiments.

[0046] Figure 1 This is a block diagram illustrating the principle of the medication status confirmation module of this utility model.

[0047] Figure 2 This is a block diagram of the principle of an integrated drug system;

[0048] Figure 3 This is a block diagram illustrating the principle of an integrated smart pillbox system.

[0049] Figure 4 This is a block diagram of the principle of a mobile terminal integrated system;

[0050] Figure 5 This is a block diagram of the integrated system principle for wearable devices. Detailed Implementation

[0051] Exemplary embodiments of the present invention will now be described in more detail with reference to the accompanying drawings. While exemplary embodiments of the present invention are shown in the drawings, it should be understood that the present invention may be implemented in various forms and should not be limited to the embodiments set forth herein. Rather, these embodiments are provided to enable a more thorough understanding of the present invention and to fully convey the scope of the present invention to those skilled in the art.

[0052] like Figure 1 As shown, this embodiment provides a medication status confirmation module, including:

[0053] The trigger module is used to generate a trigger signal in response to the user's confirmation action of completing medication administration;

[0054] A feedback module is configured to provide a status feedback signal for a predetermined duration under the control of the trigger signal; wherein, during the duration, the status feedback signal provides continuous visual feedback or interactive voice feedback to indicate that medication has been taken recently.

[0055] The confirmation action may include physical interaction or electronic sensing signal; the physical interaction includes: squeezing the capsule, tearing open the packaging seal, pressing a button or touching the sensing area, etc.

[0056] The electronic sensing signal may be a signal generated by a voice recognition unit, which is used to receive and parse the user's voice commands. When a preset command related to confirming medication is recognized, the trigger signal is generated.

[0057] The electronic sensing signal may be a signal generated by an image recognition unit, which is used to capture and analyze images of the user's medication-taking actions. When a preset medication-taking action is detected, the trigger signal is generated.

[0058] The electronic sensing signal, when discussing the example of a smart pillbox, refers to the signal generated by a sensor built into it; the sensor automatically generates the trigger signal after detecting the user taking the medicine or touching the pillbox.

[0059] The smart pillbox has built-in sensors including pressure sensors, switch sensors, photoelectric sensors, and / or camera sensors.

[0060] The predetermined duration is configured to cover the peak periods when users experience memory uncertainty and medication anxiety after taking the medication.

[0061] The method for confirming medication status based on the above modules includes the following steps:

[0062] The trigger step generates a trigger signal in response to the user completing the medication administration action.

[0063] A feedback step is used to provide a status feedback signal for a predetermined duration under the control of the trigger signal; wherein, during the duration, the status feedback signal provides continuous visual feedback or interactive voice feedback to indicate that a medication has recently been taken.

[0064] The core idea of ​​the aforementioned medication status confirmation modules is to transform a one-time medication-taking action into a continuous status feedback signal (visual or auditory) through a closed-loop "trigger-feedback" logic. That is, while the user is taking the medication, a feedback signal is triggered for a predetermined duration, serving as physical evidence of "medication taken." This effectively prevents duplicate or missed doses, fundamentally solving the problem of medication confirmation and traceability, and alleviating the user's anxiety about "whether or not medication has been taken."

[0065] The aforementioned medication status confirmation module is a functional unit designed to effectively prevent duplicate or missed doses. Based on trigger-feedback logic, it can be independently packaged or integrated into the medication status confirmation system. Its specific implementation forms include, but are not limited to, capsules, coatings, chambers, encapsulation bodies, and integrated circuit units. The medication status confirmation system can exist in various forms, such as a drug-integrated system, a smart pillbox-integrated system, a mobile terminal-integrated system, a wearable device-integrated system, or a multi-system collaborative approach.

[0066] Among them, drug-integrated systems mainly use chemiluminescence or color-changing feedback modules. Smart pillbox integrated systems, mobile terminal integrated systems, and wearable device integrated systems mainly use electronic feedback modules, such as electroluminescence feedback modules or interactive voice feedback modules, and these systems can also work together.

[0067] The following will illustrate several different types of carriers through specific embodiments:

[0068] Example 1: The medication status confirmation system is a drug-integrated system.

[0069] like Figure 2As shown, the integrated drug system includes a drug packaging unit containing at least one drug and a chemiluminescence or chemichromic time indication module paired with each drug. The drug packaging unit can adopt a conventional unit-dose packaging format, such as blister packaging (commonly aluminum-plastic or aluminum-aluminum packaging). This packaging format is suitable for various drugs (solid dosage forms), including but not limited to tablets, hard capsules, soft capsules, and pills. The chemiluminescence or chemichromic time indication module serves as a trigger and feedback module, primarily used to activate chemiluminescence or chemichromic change under trigger signal control and maintain it for a predetermined duration. The predetermined duration can be controlled by techniques known in the art, such as, but not limited to, selecting chemical substances with different reaction rates, adjusting the concentration ratio of reactants, or adjusting the total amount of reactants.

[0070] The duration of the light emission or color change preferably covers the peak anxiety period. Preferably, the duration is set to 0.5 to 4 hours, for example, 3 hours. Those skilled in the art will understand that the above duration can be adaptively adjusted according to different drugs and the psychological characteristics of different user groups. As long as it can effectively cover the peak anxiety period after the user takes the medication, it falls within the protection scope of this utility model.

[0071] (1) Chemiluminescence form:

[0072] Specifically, the chemiluminescence time indication module is in the form of a capsule, which contains a first chemical component and a second chemical component that are isolated from each other. After the first chemical component and the second chemical component break and mix inside the capsule, they activate chemiluminescence and maintain it for a predetermined time.

[0073] The wall material of the chemiluminescent timing capsule can be a commonly used natural or synthetic polymer material with good light transmittance, such as, but not limited to, gelatin-gum arabic composite system, polyvinyl alcohol, polyurea, etc. The chemiluminescent substances (first chemical component and second chemical component) include, but are not limited to, oxalate esters and fluorescent dye systems, which are respectively encapsulated in mutually isolated microcapsules.

[0074] In a preferred embodiment, the microcapsule wall material is a gelatin-gum arabic composite system, prepared by complex coagulation, with a wall thickness controlled within the range of 50-100 micrometers. The chemiluminescent substance can be an oxalate ester and fluorescent dye system, with a concentration configuration that allows for a stable luminescence duration of 3-4 hours, sufficient to cover the first half of the dosing interval, providing the user with ample confirmation time. It should be understood that the above parameters are merely examples and can be adjusted according to actual needs.

[0075] When a user takes the medication, physical triggering, such as squeezing or breaking the capsule, can cause the first and second chemical components to mix and activate chemiluminescence, which will then persist for a certain period. If a user is unsure whether they have taken the medication within the prescribed window, they can confirm this by observing the chemiluminescence.

[0076] (2) Chemical color change form:

[0077] As a form of chemical color change, similar to the principle of chemiluminescence evoked by mixing the two chemical components mentioned above, chemical color change can also be evoked by mixing the two chemical components.

[0078] As another form of chemical color change, a color-changing process can be activated by the chemical color-changing component upon contact with air, which lasts for a predetermined duration.

[0079] Specifically, the drug packaging is a blister pack, each unit of which has at least two independent chambers arranged side by side; the at least two independent chambers include a first chamber for containing the drug and a second chamber for coating a chemically discoloring component; the first chamber and the second chamber share the same aluminum foil sealing layer;

[0080] The chemical color-changing components in the second chamber activate a color change process that lasts for a predetermined duration after the aluminum foil sealing layer is torn open and exposed to air.

[0081] The chemically color-changing component coated in the second chamber comprises ferrous sulfate hydrogel. When the aluminum foil sealing layer is torn open and exposed to air, the ferrous ions (Fe²⁺) in the ferrous sulfate hydrogel within the second chamber are oxidized to ferric ions (Fe³⁺), resulting in a color change lasting for a predetermined duration. By adjusting the initial concentration of ferric ions in the gel, the entire duration of the color change can be controlled within the range of 3 to 4 hours, effectively covering the first half of the interval between two doses and providing the user with a clear basis for status confirmation. Those skilled in the art should understand that the above duration and material parameters are merely examples and can be adjusted according to the specific drug's dosing cycle and user needs.

[0082] When a user takes the medication, a destructive action such as tearing the packaging can expose the chemically color-changing component to air, thereby activating a color change process that lasts for a predetermined duration. If a user is unsure whether to take the medication within the prescribed window, they can confirm whether they have recently taken the medication by observing the current color state of the chemically color-changing component.

[0083] Example 2: Medication status confirmation system is an integrated smart pillbox system.

[0084] like Figure 3As shown, the integrated smart pillbox system includes a shell, a pillbox, a control module, a trigger module, and a feedback module. The pillbox is located inside the shell, and the trigger module and feedback module are located on the smart pillbox. The trigger module is connected to the feedback module through the control module. The control module is configured to control the feedback module to work continuously for a predetermined time once a trigger signal is received.

[0085] The triggering module uses a confirmation button, voice confirmation, or a sensor built into the smart pillbox (such as a pressure sensor, switch sensor, photoelectric sensor, or camera sensor). The sensor built into the smart pillbox automatically generates a trigger signal after detecting the medication taking action. The feedback module is an indicator light or a display icon on the screen. The indicator light can be in the form of an LED light strip. The feedback module continuously displays a preset duration in a constant, flashing, or gradual change manner. Alternatively, the feedback module can be an interactive voice feedback module, which provides corresponding voice feedback based on whether the user has taken the medication after receiving a query request from the user to confirm the medication status.

[0086] When a user takes medication, the trigger module is activated, such as by pressing a dedicated confirmation button on the smart pillbox, or by the built-in sensors (such as pressure sensors, switch sensors, photoelectric sensors, and / or camera sensors) automatically generating a trigger signal after detecting the medication-taking action. This trigger controls the feedback module to emit an electronic light for a certain period. If the user is unsure whether to take the medication within the medication window, they can confirm whether they have recently taken it by observing the electronic light. Alternatively, the feedback module can be an interactive voice feedback module; if the user is unsure whether to take the medication within the medication window, they can confirm whether they have recently taken it by asking a question and receiving a voice response from the smart pillbox.

[0087] The display duration preferably covers the peak anxiety period. Preferably, the duration is set to 0.5 to 4 hours, for example, 3 hours. Those skilled in the art will understand that the above duration can be adaptively adjusted according to different drugs and the psychological characteristics of different user groups. As long as it can effectively cover the peak anxiety period after the user takes the medication, it falls within the protection scope of this utility model.

[0088] Example 3: Mobile terminal integrated system.

[0089] like Figure 4 As shown, the mobile terminal integrated system includes a mobile terminal body and a mobile terminal screen. The mobile terminal screen is equipped with a trigger module and a feedback module.

[0090] The triggering module is a digital triggering module, which generates a trigger signal through user clicks or voice confirmation commands on the mobile terminal screen;

[0091] The feedback module is an indicator light or a display icon on a screen, which continuously displays a predetermined duration using a constant, flashing, or gradual change method. The display icon can be a continuous countdown icon or symbol. Alternatively, the feedback module can be an interactive voice feedback module, which provides corresponding voice feedback based on whether the user has taken their medication after receiving a query request from the user confirming their medication status.

[0092] When a user takes medication, a digital trigger can be used, such as a confirmation command from the user's mobile app screen or voice, to generate a trigger signal. This trigger controls the feedback module to emit an electronic light that lasts for a certain period. If a user is unsure whether to take medication within the medication window, they can confirm whether they have recently taken the medication by observing the electronic light. Alternatively, the feedback module can be an interactive voice feedback module; if a user is unsure whether to take medication within the medication window, they can confirm whether they have recently taken the medication by asking a question and receiving a voice response from the mobile terminal.

[0093] The display duration preferably covers the peak anxiety period. Preferably, the duration is set to 0.5 to 4 hours, for example, 3 hours. Those skilled in the art will understand that the above duration can be adaptively adjusted according to different drugs and the psychological characteristics of different user groups. As long as it can effectively cover the peak anxiety period after the user takes the medication, it falls within the protection scope of this utility model.

[0094] Example 4: The medication status confirmation system is a wearable device integrated system.

[0095] like Figure 5 As shown, the wearable device integrated system includes a wearable device body, a control module, a trigger module, and a feedback module;

[0096] The triggering module uses a physical button, touch sensor, capacitive sensing area, voice receiving module or camera module; the feedback module includes a miniature LED light array, optical fiber, display label on the display screen of the device itself; or the feedback module is an interactive voice feedback module; after receiving a query request from the user to confirm the medication status, the voice feedback module provides corresponding voice feedback according to whether the medication has been taken.

[0097] The control module is configured to: once it receives a trigger signal from the user through the trigger module, set the medication status to "medication taken" and continue for a predetermined duration; when the user wants to know whether the medication has been taken, provide medication status information through vision or hearing, thereby providing a visual status indication that is bound to the user's identity, always on their person, and extremely convenient.

[0098] The aforementioned wearable device integrated systems include, but are not limited to, smart rings, smart bracelets, smartwatches, or smart badges.

[0099] When a user takes medication, the trigger module is activated, such as through a physical button, touch sensor, capacitive sensing area, or voice receiving module. This generates a trigger signal, which in turn controls the feedback module to remain constantly lit, flashing, changing color (e.g., dimming), or displaying graphic animations for a predetermined duration. This provides a user-identified, always-on, and extremely convenient visual status indicator. Alternatively, the feedback module can be an interactive voice feedback module; if a user is unsure whether to take medication within the medication window, they can confirm whether they have recently taken the medication by asking a question and receiving a voice response from the wearable device. Users can also confirm whether they have recently taken medication by observing the visual status indicator.

[0100] The display duration preferably covers the peak anxiety period. Preferably, the duration is set to 0.5 to 4 hours, for example, 3 hours. Those skilled in the art will understand that the above duration can be adaptively adjusted according to different drugs and the psychological characteristics of different user groups. As long as it can effectively cover the peak anxiety period after the user takes the medication, it falls within the protection scope of this utility model.

[0101] Example 5: The medication status confirmation system is a collaborative system.

[0102] The integrated smart pillbox system, mobile terminal system, and wearable device system in embodiments 2, 3, and 4 above can not only work independently but also form a collaborative system. The systems are connected via wired or wireless communication (such as Bluetooth or NFC). For example, the integrated smart pillbox system, mobile terminal system, or smart speaker system can trigger a signal to the user-worn wearable device system, causing its feedback module to display a status. This collaborative setup physically separates the triggering action from the status display, further enhancing usability.

[0103] In summary, the medication status confirmation system of this utility model can exist in multiple carrier forms and has multiple triggering and feedback modes. It can confirm the user's medication behavior and provide continuous and intuitive status feedback through a clear and reliable mechanism, thus serving as physical evidence of "medication taken". It is particularly suitable for solving the management problems of duplicate and missed medication.

[0104] The above description is merely a preferred embodiment of the present utility model and is not intended to limit the present utility model in any way. Any simple modifications, equivalent changes or alterations made by those skilled in the art using the above-disclosed technical content shall fall within the protection scope of the present utility model.

Claims

1. A medication status confirmation module, characterized in that, include: The trigger module is used to generate a trigger signal in response to the user's confirmation action of completing medication administration; A feedback module is configured to provide a status feedback signal for a predetermined duration under the control of the trigger signal; wherein, during the duration, the status feedback signal provides continuous visual feedback or interactive voice feedback to indicate that medication has been taken recently.

2. The medication status confirmation module according to claim 1, characterized in that, The predetermined duration is configured to cover the peak periods when users experience memory uncertainty and medication anxiety after taking the medication.

3. A medication administration status confirmation system, characterized in that, It integrates the medication status confirmation module as described in claim 1 or 2.

4. The medication status confirmation system according to claim 3, characterized in that, The medication status confirmation system is a drug-integrated system; The integrated drug system includes a drug packaging body, which is provided with at least one drug and a chemiluminescence or chemichromic time indication module paired with each drug; the chemiluminescence or chemichromic time indication module serves as the trigger module and feedback module, and is used to activate chemiluminescence or chemichromic change under the control of a trigger signal and maintain it for a predetermined duration.

5. The medication status confirmation system according to claim 4, characterized in that, The chemiluminescence or chemical color change time indication module is in the form of a capsule, which contains a first chemical component and a second chemical component that are isolated from each other. After the first chemical component and the second chemical component are mixed after the capsule is broken, the chemiluminescence or chemical color change is activated and maintained for a predetermined time.

6. The medication status confirmation system according to claim 4, characterized in that, The drug packaging is a blister pack, each unit of which has at least two independent chambers arranged side by side; the at least two independent chambers include a first chamber for containing the drug and a second chamber for coating a chemically discoloring component; the first chamber and the second chamber share the same aluminum foil sealing layer; The chemical color-changing components in the second chamber activate a color change process that lasts for a predetermined duration after the aluminum foil sealing layer is torn open and exposed to air.

7. The medication status confirmation system according to claim 6, characterized in that, The chemical color-changing component contained in the second chamber includes ferrous sulfate hydrogel; the ferrous sulfate hydrogel in the second chamber oxidizes upon contact with air after the aluminum foil sealing layer is torn, thereby producing a color change that lasts for a predetermined period of time.

8. The medication status confirmation system according to claim 3, characterized in that, The feedback module is an electronic feedback module, and the medication status confirmation system is an integrated system of smart pillbox, mobile terminal, and / or wearable device.

9. The medication status confirmation system according to claim 8, characterized in that, The intelligent pillbox integrated system includes a shell, a pillbox, a control module, a trigger module, and a feedback module; The medicine compartment is located inside the shell, and the trigger module and feedback module are located on the smart medicine box. The trigger module is connected to the feedback module through the control module. The control module is configured such that once a trigger signal is received, the control feedback module continues to work for a predetermined duration. The triggering module uses a confirmation button, voice confirmation, or a sensor built into the smart pillbox. The sensor built into the smart pillbox automatically generates a trigger signal after detecting a medicine-taking action. The smart pillbox has built-in sensors, including pressure sensors, switch sensors, photoelectric sensors, or camera sensors. The feedback module is an indicator light or a display icon on the screen; the feedback module continuously displays for a predetermined duration in a constant, flashing, or gradual manner; or the feedback module is a voice feedback module; after receiving a query request from the user to confirm the medication status, the voice feedback module provides corresponding voice feedback based on whether the medication has been taken.

10. The medication status confirmation system according to claim 8, characterized in that, The mobile terminal integrated system includes a mobile terminal body and a mobile terminal screen, and the trigger module and feedback module are provided on the mobile terminal screen. The triggering module is a digital triggering module, which generates a trigger signal through user clicks or voice confirmation commands on the mobile terminal screen; The feedback module is an indicator light or a display icon on the screen, which continuously displays for a predetermined duration in a constant, flashing, or gradual manner; or the feedback module is a voice feedback module; after receiving a query request from the user to confirm the medication status, the voice feedback module provides corresponding voice feedback based on whether the medication has been taken.

11. The medication status confirmation system according to claim 8, characterized in that, The wearable device integrated system includes a wearable device body, a control module, and the trigger module and feedback module; The triggering module can be a physical button, a touch sensor, a capacitive sensing area, a voice receiving module, or a camera module. The feedback module includes a miniature LED array, optical fiber, or a display indicator on the device's own screen; or the feedback module is a voice feedback module; after receiving a user's query request to confirm medication status, the voice feedback module provides corresponding voice feedback based on whether the user has taken medication. The control module is configured to: once it receives a trigger signal from the user through the trigger module, set the medication status to "medication taken" and continue for a predetermined duration; when the user wants to obtain information on whether the medication has been taken, provide medication status information through vision or hearing, thereby providing a status indication that is bound to the user's identity, always on their person, and extremely convenient.

12. The medication status confirmation system according to claim 11, characterized in that, The wearable device integrated system includes smart rings, smart bracelets, smartwatches, or smart badges.

13. The medication status confirmation system according to any one of claims 8-12, characterized in that, The smart pillbox integrated system, mobile terminal integrated system, and wearable device integrated system are a collaborative system. Through wired or wireless communication connection, the smart pillbox integrated system and mobile terminal integrated system automatically send a trigger signal to the wearable device integrated system worn by the user, triggering the feedback module of the wearable device integrated system to display the information.

Images